These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6631711)

  • 1. Pharmacokinetics of chlorzoxazone in humans.
    Desiraju RK; Renzi NL; Nayak RK; Ng KT
    J Pharm Sci; 1983 Sep; 72(9):991-4. PubMed ID: 6631711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pedigree analysis of a subject with abnormally slow renal elimination of 6-hydroxychlorzoxazone.
    Vesell ES; Korsunsky Z
    Pharmacology; 1998 May; 56(5):262-6. PubMed ID: 9597694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
    Poloyac SM; Tosheva RT; Gardner BM; Shedlofsky SI; Blouin RA
    Clin Pharmacol Ther; 1999 Dec; 66(6):554-62. PubMed ID: 10613610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.
    O'Shea D; Davis SN; Kim RB; Wilkinson GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of chlorzoxazone and its metabolite 6-hydroxychlorzoxazone in plasma by HPLC and their pharmacokinetics].
    Li L; Zhang Y
    Yao Xue Xue Bao; 1998 Oct; 33(10):731-6. PubMed ID: 12016924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.
    Burckart GJ; Frye RF; Kelly P; Branch RA; Jain A; Fung JJ; Starzl TE; Venkataramanan R
    Clin Pharmacol Ther; 1998 Mar; 63(3):296-302. PubMed ID: 9542473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of chlorzoxazone metabolites in human urine (author's transl)].
    Twele R; Spiteller G
    Arzneimittelforschung; 1982; 32(7):759-63. PubMed ID: 6889877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography.
    Frye RF; Stiff DD
    J Chromatogr B Biomed Appl; 1996 Nov; 686(2):291-6. PubMed ID: 8971612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
    Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
    Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorometric determination of chlorzoxazone in tablets and biological fluids.
    Stewart JT; Chan CW
    J Pharm Sci; 1979 Jul; 68(7):910-2. PubMed ID: 458615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans.
    Lucas D; Berthou F; Girre C; Poitrenaud F; Ménez JF
    J Chromatogr; 1993 Dec; 622(1):79-86. PubMed ID: 8120116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
    Baek HW; Bae SK; Lee MG; Sohn YT
    J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
    Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
    Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing.
    Witt L; Suzuki Y; Hohmann N; Mikus G; Haefeli WE; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():207-13. PubMed ID: 27300008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
    Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
    Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.